Covered recipient · General Payments record
FRANCOIS PICOT
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2022–2023
$668.49
- Reported across 42 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $479.01 | 31 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $242.12 | 19 |
| PFIZER INC. | $64.50 | 3 |
| Lilly USA, LLC | $49.89 | 3 |
| IMPEL PHARMACEUTICALS INC. | $24.67 | 1 |
| UPSHER-SMITH LABORATORIES LLC | $22.49 | 1 |
| ARGENX US, INC. | $21.90 | 1 |
| Biogen, Inc. | $20.50 | 1 |
| Celgene Corporation | $19.47 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $13.47 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (31)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $6.02 | 01/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998138165 | CMS |
| ABBVIE INC. | $18.42 | 01/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998138167 | CMS |
| ABBVIE INC. | $3.83 | 02/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998138169 | CMS |
| ABBVIE INC. | $8.52 | 02/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998138171 | CMS |
| ABBVIE INC. | $21.04 | 03/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998138173 | CMS |
| ABBVIE INC. | $14.40 | 03/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998138175 | CMS |
| ABBVIE INC. | $16.63 | 04/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998138177 | CMS |
| ABBVIE INC. | $19.88 | 04/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998138179 | CMS |
| ABBVIE INC. | $25.79 | 06/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998138181 | CMS |
| ABBVIE INC. | $30.99 | 06/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998138183 | CMS |
| ABBVIE INC. | $5.63 | 07/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998138185 | CMS |
| ABBVIE INC. | $14.60 | 07/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998138187 | CMS |
| ABBVIE INC. | $6.20 | 07/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998138189 | CMS |
| ABBVIE INC. | $7.03 | 07/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998138191 | CMS |
| ABBVIE INC. | $6.23 | 08/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998138193 | CMS |
| ABBVIE INC. | $6.23 | 08/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998138197 | CMS |
| ABBVIE INC. | $14.73 | 08/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998138199 | CMS |
| ABBVIE INC. | $7.08 | 08/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998138201 | CMS |
| ABBVIE INC. | $8.87 | 09/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998138203 | CMS |
| ARGENX US, INC. | $21.90 | 02/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1060411699 | CMS |
| Biogen, Inc. | $20.50 | 09/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1012288257 | CMS |
| Celgene Corporation | $19.47 | 07/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015815339 | CMS |
| IMPEL PHARMACEUTICALS INC. | $24.67 | 08/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 989372881 | CMS |
| Lilly USA, LLC | $18.24 | 05/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031470891 | CMS |
| Lilly USA, LLC | $18.38 | 07/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031402355 | CMS |
| Lilly USA, LLC | $13.27 | 09/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031424069 | CMS |
| Novartis Pharmaceuticals Corporation | $13.47 | 05/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 992905921 | CMS |
| PFIZER INC. | $15.07 | 02/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049578381 | CMS |
| PFIZER INC. | $25.05 | 03/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050280605 | CMS |
| PFIZER INC. | $24.38 | 08/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049891407 | CMS |
| UPSHER-SMITH LABORATORIES LLC | $22.49 | 01/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 994137831 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023
- Source files
- Dataset page · Bulk file · PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.